DE2661014C2 - - Google Patents

Info

Publication number
DE2661014C2
DE2661014C2 DE2661014A DE2661014A DE2661014C2 DE 2661014 C2 DE2661014 C2 DE 2661014C2 DE 2661014 A DE2661014 A DE 2661014A DE 2661014 A DE2661014 A DE 2661014A DE 2661014 C2 DE2661014 C2 DE 2661014C2
Authority
DE
Germany
Prior art keywords
pyrrolo
cyan
benzazepin
water
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2661014A
Other languages
German (de)
English (en)
Other versions
DE2661014A1 (sv
Inventor
Joshua Chomedey Laval Quebec Ca Rokach
Joseph George Montreal Quebec Ca Atkinson
Clarence Stanley Beaconsfield Quebec Ca Rooney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2661014A1 publication Critical patent/DE2661014A1/de
Application granted granted Critical
Publication of DE2661014C2 publication Critical patent/DE2661014C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE2661014A 1975-07-02 1976-07-02 Expired DE2661014C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59243675A 1975-07-02 1975-07-02

Publications (2)

Publication Number Publication Date
DE2661014A1 DE2661014A1 (sv) 1985-07-04
DE2661014C2 true DE2661014C2 (sv) 1989-01-05

Family

ID=24370639

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2661014A Expired DE2661014C2 (sv) 1975-07-02 1976-07-02
DE19762629877 Granted DE2629877A1 (de) 1975-07-02 1976-07-02 Pyrrolo eckige klammer auf 2,1-b eckige klammer zu eckige klammer auf 3 eckige klammer zu benzazepine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19762629877 Granted DE2629877A1 (de) 1975-07-02 1976-07-02 Pyrrolo eckige klammer auf 2,1-b eckige klammer zu eckige klammer auf 3 eckige klammer zu benzazepine

Country Status (18)

Country Link
JP (1) JPS527996A (sv)
AU (1) AU499122B2 (sv)
BE (1) BE843678A (sv)
CA (1) CA1092105A (sv)
CH (5) CH626366A5 (sv)
CY (1) CY1091A (sv)
DE (2) DE2661014C2 (sv)
ES (1) ES449432A1 (sv)
FR (1) FR2315935A1 (sv)
GB (1) GB1499047A (sv)
GR (1) GR60851B (sv)
HK (1) HK60580A (sv)
HU (1) HU177866B (sv)
MY (1) MY8100227A (sv)
NL (1) NL188287C (sv)
PT (1) PT65295B (sv)
SE (1) SE424076B (sv)
ZA (1) ZA763990B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
JPH0487401U (sv) * 1990-12-06 1992-07-29
US6271392B1 (en) 1994-10-07 2001-08-07 Rhone-Poulenc Inc. Intermediates useful for the synthesis of 1-arylpyrrole pesticides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428677A (en) * 1962-09-24 1969-02-18 Merck & Co Inc Chemical compounds and methods of preparing same
US3499037A (en) * 1966-05-31 1970-03-03 Merck & Co Inc Preparation of trifluoromethyl substituted dibenzocycloheptenes

Also Published As

Publication number Publication date
DE2629877A1 (de) 1977-01-20
NL7607347A (nl) 1977-01-04
CA1092105A (en) 1980-12-23
GB1499047A (en) 1978-01-25
JPS527996A (en) 1977-01-21
DE2661014A1 (sv) 1985-07-04
GR60851B (en) 1978-08-31
MY8100227A (en) 1981-12-31
FR2315935A1 (fr) 1977-01-28
CH626366A5 (en) 1981-11-13
CY1091A (en) 1980-12-27
AU499122B2 (en) 1979-04-05
AU1548876A (en) 1978-01-05
FR2315935B1 (sv) 1978-11-17
JPH0132225B2 (sv) 1989-06-29
BE843678A (fr) 1977-01-03
PT65295A (en) 1976-07-01
HK60580A (en) 1980-11-07
SE424076B (sv) 1982-06-28
CH626617A5 (en) 1981-11-30
CH626616A5 (en) 1981-11-30
NL188287B (nl) 1991-12-16
DE2629877C2 (sv) 1989-01-05
ZA763990B (en) 1978-02-22
CH626893A5 (en) 1981-12-15
HU177866B (en) 1982-01-28
SE7607534L (sv) 1977-01-03
CH626618A5 (en) 1981-11-30
ES449432A1 (es) 1977-12-16
PT65295B (en) 1978-05-10
NL188287C (nl) 1992-05-18

Similar Documents

Publication Publication Date Title
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
DE2614406C2 (sv)
CA1168244A (en) Process for 5-aroylation of 1,2-dihydro-3h- pyrrolo[1,2-a]pyrrole-1-carboxylic esters
DE1445848A1 (de) Verfahren zur Herstellung eines neuen Isoxazolderivates
DE2661014C2 (sv)
McEwen et al. 1, 3-Dipolar addition reactions of Reissert compounds
DE60218646T2 (de) N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- und tricyclische azepine und diazepine als vasopressin-agonisten
DE2726389A1 (de) Pyrazolo eckige klammer auf 1,5-c eckige klammer zu chinazoline, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4753950A (en) Fused heterocyclic tetrahydroaminoquinolinols and related compounds
DE3787790T2 (de) Indenderivate und Verfahren.
US4075225A (en) Pyrrolo[2,1-b][3]benzazepines
CH645360A5 (de) Verfahren zur herstellung von 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon.
CH654007A5 (de) 9-brom-indolochinolizin-derivate und verfahren zu deren herstellung.
DE2642608C2 (de) Verfahren zur Herstellung eines 4-Hydroxymethyl-2-pyrrolidinons
EP0302227B1 (de) 5-Halogen-6-amino-nikotin-säurehalogenide, ihre Herstellung und ihre Verwendung
DE3017564A1 (de) Geminale dihalogenderivate kondensierter pyrimidin-4-on-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische kompositionen
EP0004322A1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
EP0090769B1 (de) Verfahren zur Herstellung von 1,2,5,6-Tetrahydro-4H-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5-Halogen-1,2,3-(1,2-dihydropyrrolo)-4-chinolone als Zwischenprodukte zur Durchführung des Verfahrens
DE1770421C3 (de) Verfahren zur Herstellung von 1,3-Dihydro-2H-1,4-benzodiazepin-2-onderivaten
Anderson et al. The synthesis of polycyclic benz‐fused pyrroles
DE1795758A1 (de) Verfahren zur herstellung von 5hydroxy-5-phenyl-2,3-dihydro-5h-imidazo eckige klammer auf 2,1-a eckige klammer zu isoindolen
DE2521326A1 (de) Neue thienodiazepinderivate, verfahren zur herstellung derselben und diese enthaltende pharmazeutische mittel
AT274821B (de) Verfahren zur Herstellung von neuen in 11-Stellung substituierten 5,11-Dihydro-6 H-pyrido[2,3-b][1,4]benzodiazepin-6-onen
AT256107B (de) Verfahren zur Herstellung von neuen Aza-dibenzo-cycloheptenderivaten
CH634559A5 (de) Verfahren zur herstellung von 3-halogen-3-kohlenwasserstoffthio-oxindolen und verfahren zur herstellung von isatinen.

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2629877

8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: ROKACH, JOSHUA, CHOMEDEY LAVAL, QUEBEC, CA ATKINSON, JOSEPH GEORGE, MONTREAL, QUEBEC, CA ROONEY, CLARENCE STANLEY, BEACONSFIELD, QUEBEC, CA

AC Divided out of

Ref country code: DE

Ref document number: 2629877

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee